BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

960 related articles for article (PubMed ID: 33879592)

  • 1.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879592
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Clemmensen HS; Dube JY; McIntosh F; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Behr MA; Mortensen R
    bioRxiv; 2021 Feb; ():. PubMed ID: 33564764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.
    Clemmensen HS; Knudsen NPH; Billeskov R; Rosenkrands I; Jungersen G; Aagaard C; Andersen P; Mortensen R
    Front Immunol; 2020; 11():585359. PubMed ID: 33240275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis.
    Moguche AO; Musvosvi M; Penn-Nicholson A; Plumlee CR; Mearns H; Geldenhuys H; Smit E; Abrahams D; Rozot V; Dintwe O; Hoff ST; Kromann I; Ruhwald M; Bang P; Larson RP; Shafiani S; Ma S; Sherman DR; Sette A; Lindestam Arlehamn CS; McKinney DM; Maecker H; Hanekom WA; Hatherill M; Andersen P; Scriba TJ; Urdahl KB
    Cell Host Microbe; 2017 Jun; 21(6):695-706.e5. PubMed ID: 28618268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
    Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
    J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
    Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
    Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.
    Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P
    J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine potential of ESAT-6 protein fused with consensus CD4
    Choi SY; Kwon KW; Kim H; Choi HH; Shin SJ
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2195-2201. PubMed ID: 29894686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.
    Muflihah H; Flórido M; Lin LCW; Xia Y; Triccas JA; Stambas J; Britton WJ
    Vaccine; 2018 Apr; 36(18):2462-2470. PubMed ID: 29602704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T Cells Primed by Live Mycobacteria Versus a Tuberculosis Subunit Vaccine Exhibit Distinct Functional Properties.
    Lindenstrøm T; Moguche A; Damborg M; Agger EM; Urdahl K; Andersen P
    EBioMedicine; 2018 Jan; 27():27-39. PubMed ID: 29249639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo.
    Kupz A; Zedler U; Stäber M; Perdomo C; Dorhoi A; Brosch R; Kaufmann SH
    J Clin Invest; 2016 Jun; 126(6):2109-22. PubMed ID: 27111234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection.
    Dalmia N; Klimstra WB; Mason C; Ramsay AJ
    PLoS One; 2015; 10(8):e0136635. PubMed ID: 26317509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.
    Silva-Sánchez A; Meza-Pérez S; Flores-Langarica A; Donis-Maturano L; Estrada-García I; Calderón-Amador J; Hernández-Pando R; Idoyaga J; Steinman RM; Flores-Romo L
    PLoS One; 2015; 10(4):e0124828. PubMed ID: 25915045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
    Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
    J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM; Kang L; Wang XH
    Microbiol Immunol; 2009 Jul; 53(7):384-90. PubMed ID: 19563397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.